Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | GHSR | Q92847 | 2/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7962303 | 0.80 | GHSR (0.38) | GLATSHRNAALAD2KDM4EMEN1 | |
| SCHEMBL7962305 | 0.80 | GHSR (0.38) | GLATSHRNAALAD2KDM4EMEN1 | |
| SCHEMBL7976213 | 0.78 | GHSR (0.40) | TSHRNAALAD2MEN1ALDH1A1MAPT | |
| SCHEMBL7976216 | 0.65 | GHSR (0.48) | TSHRNAALAD2MEN1ALDH1A1MAPT | |
| SCHEMBL7976208 | 0.65 | GHSR (0.48) | TSHRNAALAD2MEN1ALDH1A1MAPT | |
| SCHEMBL22924247 | 0.64 | MEN1 (0.56) | GLAKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL19436178 | 0.62 | ESR1 (0.48) | GLATSHRNAALAD2MEN1ALDH1A1 | |
| SCHEMBL19436179 | 0.62 | ESR1 (0.48) | GLATSHRNAALAD2MEN1ALDH1A1 | |
| SCHEMBL30765796 | 0.61 | MEN1 (0.53) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL3707997 | 0.61 | GHSR (0.46) | GLATSHRNAALAD2CYP2D6GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001077095-A2 | DERIVATIVES OF ALPHA-MERCAPTOACETAMIDE | NOVARTIS AG (CH) | 2001-10-18 | — | — | WO | disclosed |